Bing

SEARCH HISTORY

Looking back to 34 days ago, Inovio Pharmaceuticals Inc. (Symbol: INO) priced a 9,500,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company …
NASDAQ · 5 hours ago
Advancements in this treatment could present a catalyst for INO share price appreciation in the stock market. Inovio plans to initiate a Phase I trial with INO-5150 for the treatment of prostate cancer in the first half of …
Seeking Alpha · ByBret Jensen · 5/29/2015
Inovio Pharmaceuticals Inc. (INO) experienced unusually high volume on May. 22, as the stock gained 6.9% to a closing price of $8.83. The stock saw 2.46 million shares trade hands over the course of the day on 10,547 trades. Given that the stock’s ...
Equities · 5/23/2015
Inovio Pharmaceuticals Inc
More from Bing News
On May 11, Inovio Pharmaceuticals (NASDAQ: INO), a clinical-stage biopharmaceutical company ... Inovio made all quarter was its offering of 10.925 million shares of common stock, including the shares its …
Investopedia · 5/22/2015
One of today's stocks on the move is Inovio Biomedical (AMEX:INO), down 5.3% to $8.37. The Dow is down 0.9% to 18,070 and the S&P is currently down 0.9% to 2,108. Inovio Biomedical has overhead space with shares priced $8.37, or 60.9% below the …
Financial News Network Online · ByRobert Cotter · 5/26/2015
Interested in a cure for cancer? HIV? Hepatitis B? Influenza? Inovio Pharmaceuticals Inc (NASDAQ:INO) has taken that hope on step further. It’s working on vaccines for all these. And it’s getting pretty impressive results. So much so that INO will ...
Investor Place · 4/15/2015
NEW YORK (TheStreet) -- Shares of Inovio Pharmaceuticals (INO - Get Report) are down by 16.95% to $8.18 on heavy volume in late morning trading on Thursday after the clinical-stage biopharmaceutical company announced the pricing of a public offering …
The Street · 4/30/2015
PLYMOUTH MEETING, Pa., May 27, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced it will advance its DNA vaccine for MERS (Middle East Respiratory Syndrome) into a phase I clinical trial in healthy volunteers in a …
Financial Content · 5/27/2015
MERS
Investors are always looking for stocks that are poised to beat at earnings season and Inovio Pharmaceuticals, Inc. (INO - Analyst Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for ...
ZACKS · 5/8/2015
CHICAGO, May 21, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, FCX, CELG, INO and AMBA. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
The Business Journal · 5/21/2015